Kathrin U. Jansen

35.1k citations

123 papers · 7.6k indexed · 3 hit papers · h-index 45

Impact in

Microbiology top 0.1%
- Bacterial Infections and Vaccines
Epidemiology top 0.2%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Pneumonia and Respiratory Infections

Papers in

Microbiology 42
- Bacterial Infections and Vaccines 39
Epidemiology 89
- Pneumonia and Respiratory Infections 41
- Cervical Cancer and HPV Research 38
- Hepatitis B Virus Studies 21
- Infective Endocarditis Diagnosis and Management 12

Co-authors: Robert E. Hollingsworth Darron R. Brown Eliav Barr Cosette M. Wheeler Laura A. Koutsky Annaliesa S. Anderson Kevin A. Ault Frances B. Alvarez
Journals: Vaccine (18 papers)Human Vaccines & Immunotherapeutics (9 papers)Virology (7 papers)Open Forum Infectious Diseases (5 papers)The Pediatric Infectious Disease Journal (5 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Kathrin U. Jansen

121 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants 2021 · 212 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Nature
2019 npj Vaccines
2002 New England Journal of Medicine

Peers

Countries citing papers authored by Kathrin U. Jansen

Since Specialization

Citations

This map shows the geographic impact of Kathrin U. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin U. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin U. Jansen more than expected).

Fields of papers citing papers by Kathrin U. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin U. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin U. Jansen. The network helps show where Kathrin U. Jansen may publish in the future.

Co-authors

The 25 scholars most cited alongside Kathrin U. Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kathrin U. Jansen Line = papers co-authored together Kathrin U. Jansen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine Nature Communications ·Chaitanya Kurhade, Jing Zou, Hongjie Xia, Hui Cai, Qi Yang, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Xuping Xie, Kena A. Swanson, Pei‐Yong Shi	2022	41
2	BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants npj Vaccines ·Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, Hui Cai, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Uğur Şahin, Xuping Xie, Philip R. Dormitzer, Pei‐Yong Shi	2022	6
3	Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease Human Vaccines & Immunotherapeutics ·Charu Sabharwal, Vani Sundaraiyer, Yahong Peng, B. Sozeri, Todd Belanger, Bradford D. Gessner, Luis Jódar, Kathrin U. Jansen, William C. Gruber, Daniel A. Scott, Wendy Watson	2022	2
4	Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2 Cell Host & Microbe ·Hongjie Xia, Jing Zou, Chaitanya Kurhade, Hui Cai, Qi Yang, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Xuping Xie, Kena A. Swanson, Pei‐Yong Shi	2022	64
5	BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants Nature ·Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, Hui Cai, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Uğur Şahin, Xuping Xie, Philip R. Dormitzer, Pei‐Yong Shi Hit paper breakdown →	2021	212
6	Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp) Vaccine ·Julie A. Bettinger, Paul Liberator, Scott A. Halperin, Wendy Vaudry, Manish Sadarangani, Hao Li, Jinchu Liu, Kathrin U. Jansen, Annaliesa S. Anderson, Raymond S. W. Tsang	2020	7
7	Reviving an R&D pipeline: a step change in the Phase II success rate Drug Discovery Today ·Sper Sper C Uriati, M. KUECUEK, Charlotte Allerton, Kathrin U. Jansen, Michael S. Vincent, Mikael Dolsten	2020	24
8	Meningococcal serogroup B vaccines: Estimating breadth of coverage Human Vaccines & Immunotherapeutics ·Robert G. K. Donald, I. V. Piyakov, Hao Li, Paul Liberator, Thomas R. Jones, Shannon L. Harris, John L. Perez, Joseph J. Eiden, Kathrin U. Jansen, Annaliesa S. Anderson	2016	39
9	Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents Journal of the Pediatric Infectious Diseases Society ·Timo Vesikari, Lars Østergaard, Javier Díez‐Domingo, Jacek Wysocki, Carl‐Erik Flodmark, Johannes Beeslaar, Joseph J. Eiden, Qin Jiang, Kathrin U. Jansen, Thomas R. Jones, Shannon L. Harris, Robert E. O’Neill, Laura J. York, Graham Crowther, John L. Perez	2015	45
10	13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge model Human Vaccines ·Philip Fernsten, Bartłomiej Mełges, Xinhong Yu, S. Saravanasundaram Sakthivel, 曹烨, Ashutosh Sancheti, Duzhang Zhu, David Cooper, Michael Hagen, Kathrin U. Jansen	2011	4
11	Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia Obstetrical & Gynecological Survey ·Constance Mao, Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler, Darron R. Brown, Dorothy J. Wiley, Frances B. Alvarez, Oliver Bautista, Kathrin U. Jansen, Eliav Barr	2006	21
12	Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia Obstetrics and Gynecology ·Constance Mao, Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler, Darron R. Brown, Dorothy J. Wiley, Frances B. Alvarez, Oliver Bautista, Kathrin U. Jansen, Eliav Barr	2006	338
13	Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes Virology ·نسمه صلاح, Šárka Buřilová, Loren D. Schultz, Ling Chen, Fubao Wang, Delpi Lestari, Mohamed El-Hafidi, Elmer Santos, Richard A. Moore, T J Palker, Margaret Stanley, Kathrin U. Jansen	2005	27
14	Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant PubMed ·Vikrant Kumbhar, W.L. McClements, Kathrin U. Jansen, Mark T. Esser	2005	44
15	Detection of specific human papillomavirus types in paraffin‐embedded sections of cervical carcinomas Journal of Medical Virology ·Janine T. Bryan, Frank J. Taddeo, Akinobu Wakasugi, Kathrin U. Jansen, 胡良平, Brahim Qadadri, Darron R. Brown	2005	22
16	A Novel Human Papillomavirus Type 6 Neutralizing Domain Comprising Two Discrete Regions of the Major Capsid Protein L1 Virology ·W.L. McClements, G.M. Chippendale, 勝敏佐藤, Natsuki Yabune, Neil D. Christensen, Kathrin U. Jansen, Steven W. Ludmerer	2001	31
17	The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human Keratinocytes Journal of Biological Chemistry ·Joseph G. Joyce, Jwu‐Sheng Tung, Craig T. Przysiecki, James C. Cook, E. Dale Lehman, Jeffrey A. Sands, Kathrin U. Jansen, Paul M. Keller	1999	328
18	Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: Correlation with virus-like particle IgG concentration Journal of Medical Virology ·Janine T. Bryan, Kathrin U. Jansen, Robert S. Lowe, Kenneth H. Fife, Lovise, 井原真都, Darron R. Brown	1997	31
19	Virus-like Particles and E1AE4 Protein Expressed from the Human Papillomavirus Type 11 Bicistronic E1AE4AL1 Transcript Virology ·Mohatma Kar Gandhi, Linda Pratt, Janine T. Bryan, Kenneth H. Fife, Kathrin U. Jansen	1996	15
20	Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes. The Journal of Experimental Medicine ·Sibylle Pochon, Pierre Graber, Mark P. Yeager, Kathrin U. Jansen, Linda Paterson, Jean‐Pierre Aubry, Jean‐Yves Bonnefoy	1992	60

About Kathrin U. Jansen

Kathrin U. Jansen is a scholar working on Microbiology, Epidemiology, Immunology, Infectious Diseases and Virology, having authored 123 papers that have together received 7.6k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (41 papers), Bacterial Infections and Vaccines (39 papers), Cervical Cancer and HPV Research (38 papers), Hepatitis B Virus Studies (21 papers), Immunotherapy and Immune Responses (16 papers), Virus-based gene therapy research (12 papers), Infective Endocarditis Diagnosis and Management (12 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). The work is most often cited by research in Microbiology (1.6k citations), Epidemiology (4.5k citations), Immunology (2.2k citations), Infectious Diseases (1.2k citations) and Virology (205 citations). Kathrin U. Jansen has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Robert E. Hollingsworth, Darron R. Brown, Eliav Barr, Cosette M. Wheeler, Laura A. Koutsky, Annaliesa S. Anderson, Kevin A. Ault, Frances B. Alvarez, Jean‐Yves Bonnefoy and Sibylle Pochon. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, Virology, Open Forum Infectious Diseases and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact